Targeted Α-synuclein PET Imaging in the Diagnosis of Multiple System Atrophy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Targeted Α-synuclein PET Imaging in the Diagnosis of Multiple System Atrophy — Stella

Recruiting

Back to Multiple System Atrophy - Cerebellar Subtype (MSA-C) trials

Trial locations(1 site)

China

Third Xiangya Hospital of Central South University, Hunan, Changsha

Key details

Sponsor

Min Zhao,MD

Enrollment target

~90 participants

Started

September 2024

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

35 Years – 80 Years

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov